NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Average weekly trading volume of approximately 580,845 sharesFund's adviser has more than 50 years of small- and micro-cap investment experienceCLOSING PRICES AS OF 08/31/25NAV11.54MKT10.17AVERAGE ANNUAL TOTAL RETURN AS OF 08/31/25NAV (%)MKT (%)One-Month*7.257.39Year to Date*9.648.81One-Year12.7412.85Three-Year13.8213.45Five-Year12.7013.6910-Year11.3511.81*Not AnnualizedImportant Performance and Expense InformationAll performance information reflects past performance ...

Summary of Key Points from the Conference Call Industry Overview - The reports focus on the performance of hedge funds and mutual funds, analyzing $8 trillion of equity positions at the start of Q3 2025 [3][4] - Hedge funds have returned 8% YTD, while large-cap mutual funds have also returned 8% YTD, with 39% of large-cap mutual funds outperforming their benchmarks [3][5] Core Insights - Hedge funds and mutual funds have both navigated beta and alpha headwinds to generate solid YTD returns [5] - Mutual funds have cut cash allocations to near-record lows, while hedge fund net leverage remains near its 5-year average [3][11] - Health Care and Industrials are the most overweight sectors for both fund types, while Financials have seen increased exposure from both groups [3][17][19] - Mutual funds have reduced their exposure to the "Magnificent 7" stocks, increasing their underweights from 723 basis points in Q1 to 819 basis points [3][22] - Hedge funds have increased their exposure to the Magnificent 7, with the weight in their long portfolio rising from 11.8% in Q1 to 12.8% [3][22] Notable Stock Movements - COF has seen the largest increase in popularity among fund managers based on net changes in shares owned [3] - Seven "shared favorites" this quarter include APP, CRH, MA, SCHW, SPOT, V, and VRT, which have returned 20% YTD compared to 9% for the S&P 500 [3][22] Sector Positioning - Both hedge funds and mutual funds are underweight in Technology, with mutual funds carrying the largest underweight in Info Tech on record [17][18] - Financials dominate the list of stocks with the largest increase in hedge fund popularity, with FI, NU, and SSB joining COF and BRO among the most popular mutual fund increases [19] Performance Metrics - The Hedge Fund VIP basket has returned 13% YTD, while a basket of Concentrated Shorts has returned 8% YTD after a surge of more than 60% in recent months [5] - Mutual funds have seen a decline in cash balances to 1.4% of assets, nearly a record low [11][14] Economic Indicators - The median S&P 500 stock has a short interest of 2.3% of float, ranking in the 96th percentile relative to the last 5 years [11] - The S&P 500 is forecasted to have an EPS of $246 for 2024, with a year-over-year growth of 10% [29] Conclusion - The analysis indicates a cautious but optimistic outlook for hedge funds and mutual funds, with strategic positioning in sectors like Health Care and Industrials while navigating challenges in the Technology sector [3][17][19]

Core Insights - Ingevity Corporation (NGVT) reported a second-quarter 2025 loss of $146.5 million or $4.02 per share, an improvement from a loss of $283.7 million or $7.81 per share in the same quarter last year [1] - Adjusted earnings for the quarter were $1.39 per share, up from $1.01 a year ago, surpassing the Zacks Consensus Estimate of $1.02 per share [1][9] - Revenues decreased by 6.5% year over year to $365.1 million, primarily due to lower sales in the Performance Chemicals segment [2] Segment Performance - The Performance Chemicals division generated revenues of $167.9 million, down approximately 9.5% year over year, with Road Technologies sales at $119.5 million (down 7.4%) and Industrial Specialties at $48.4 million (down 14.2%) [3] - EBITDA for the Performance Chemicals segment increased by 244% to $32 million, attributed to successful repositioning and cost savings [3] - Performance Materials revenues fell by 2.1% year over year to $153.9 million, impacted by lower sales in Asia and Europe, while North America saw higher sales; segment EBITDA was $77.1 million, down 6.2% [4] - Advanced Polymer Technologies segment sales decreased by 9.6% to $43.3 million due to reduced customer demand, particularly in Europe, with segment EBITDA down 90.8% to $0.9 million [5] Financial Overview - Operating cash flow for the second quarter was $79 million, with free cash flow of $66.8 million; no share repurchases occurred during the quarter, leaving $353.4 million remaining under the current $500 million authorization [6] - Net leverage improved to 3x from 3.3x in the previous quarter [6] 2025 Outlook - NGVT has revised its 2025 EBITDA guidance upwards, now expecting adjusted EBITDA between $390 million and $415 million, compared to the previous range of $380 million to $415 million; sales estimates remain between $1.25 billion and $1.40 billion [7][9] Stock Performance - NGVT shares have increased by 50.8% over the past year, outperforming the industry average increase of 1.2% [8]

Portfolio Highlights - The company's Manhattan-focused real estate portfolio features a tenant base in core commercial businesses, with the top 10 tenants being 77% Investment Grade rated[5, 9] - Portfolio occupancy is at 82.0%, with a weighted-average remaining lease term of 6.0 years[9] - Over 53% of the company's leases expire after 2030[9, 17] - The real estate investments are valued at $432.4 million, spread across 6 properties with a total square footage of 1.0 million[14] - Annualized Straight-line Rent is $45.1 million[14] Financial Highlights - The company has a 100% fixed-debt capital structure with a weighted-average interest rate of 6.4%[9, 38] - Total debt amounts to $350.0 million[38] - Net Leverage is at 63.8%[9, 38, 46] - Revenue from tenants for the quarter was $12.2 million, while the net loss was $41.7 million[38] - Cash NOI decreased year-over-year from $7.4 million in Q2'24 to $4.2 million in Q2'25[42, 38] Strategic Initiatives - The company continued marketing efforts for the sale of 123 William Street ($269.5 million at cost, 84% occupancy) and 196 Orchard Street ($66.6 million at cost, 100% occupancy)[9, 10, 24]

Q2 2025 Performance Highlights - Concentra's Q2 2025 total revenue increased by 152% year-over-year to $5508 million, with an 87% increase excluding the impact of the Nova acquisition[17] - Adjusted EBITDA for Q2 2025 grew by 132% year-over-year to $1150 million[17] - The number of onsite health clinics significantly increased to 406, a rise of 252 clinics, primarily due to the Pivot Onsite acquisition[17] - Revenue per visit (RPV) increased by 44% year-over-year to $146 in Q2 2025[17] YTD 2025 Performance Highlights - Total revenue for YTD 2025 increased by 112% year-over-year to $10515 billion, or 121% on a per-day basis[18] - Adjusted EBITDA for YTD 2025 increased by 101% year-over-year to $2177 million[18] - The number of occupational health centers increased to 628, a rise of 81 centers, due to the Nova acquisition and other M&A activities[18] - Revenue per visit (RPV) increased by 50% year-over-year to $146 in YTD 2025[18] Guidance and Financial Strategy - The company is raising its FY 2025 revenue guidance to $213 billion-$216 billion and Adjusted EBITDA guidance to $420 million-$430 million[16] - Concentra is targeting a net leverage ratio of less than 30x by the end of 2026[16]

Financial Performance - Second quarter Adjusted EBITDA was $282 million[6, 10], compared to $338 million in the prior quarter[10] - Free cash flow for the second quarter was $107 million[6, 10], down from $173 million in the first quarter[10] - Capital expenditures, net of insurance proceeds, were $110 million in the second quarter[10], compared to $98 million in the previous quarter[10] - The company returned over $1.1 billion to shareholders since Q4 2022, including a Q3 dividend of $0.50 per share[6] Contract Backlog and Fleet - Current contract backlog stands at $6.9 billion[10, 12], a decrease from $7.5 billion in the previous quarter[10] - Approximately $380 million in new contracts were secured[6] - 62% of floater rig days are committed for 2025, 49% for 2026, and 36% for 2027[13] - 20% of floater rig days are committed for 2028, and 5% for 2029-2031[13] Guidance and Fleet Rationalization - Full year 2025 Adjusted EBITDA guidance is $1.075 billion to $1.15 billion[32] - Full year 2025 capital additions, net of reimbursements, are guided at $400 million to $450 million[32] - Revenue guidance for 2025 is $3.2 billion to $3.3 billion[32] - The company completed the retirement of Meltem and Scirocco rigs and plans to retire Globetrotter II, Highlander, and Reacher rigs[8]

Portfolio Overview - The company's Manhattan-focused real estate portfolio features an underlying tenant base in core commercial businesses, with 77% Investment Grade rated among the top 10 tenants[4] - Portfolio Occupancy is at 82% with a weighted-average Remaining Lease Term of 5.4 years[4] - Over 51% of leases expire after 2030, based on Annualized Straight-Line Rent as of March 31, 2025[4] Property Details - Real Estate Investments are valued at $470.9 million at cost, comprising 6 properties with a total of 1.0 million square feet[12] - The portfolio generates $45.5 million in Annualized Straight-line Rent[12] - 123 William Street accounts for $269.4 million in real estate assets, 84% occupancy, 3.4 years remaining lease term, 46% of Annualized Straight-Line Rent, and 55% of Portfolio Square Feet[23] Tenant Profile - Top 10 tenants are 77% Investment Grade rated, with a Remaining Lease Term of 7.8 years[4] - The top 10 tenants contribute to 50.5% of Portfolio SLR and 42.4% of Portfolio SF[27] - Financial Services represent 26% of tenant industry diversity, followed by Government/Public Administration at 17%[15] Financial Highlights - Total Debt amounts to $350.0 million, with a weighted-average interest rate of 4.4%[36] - Net Leverage stands at 57.9%[36] - Revenue from Tenants is $12.3 million, while the Net Loss is ($8.6) million for Q1'25[36]

Portfolio Highlights - The company's real estate investments, at cost, totaled $470.8 million[8] - The portfolio consists of 6 properties with a total square footage of 1 million[8] - The portfolio's occupancy rate is 80.8%[4, 8] with a weighted-average remaining lease term of 6.3 years[4, 8] - Annualized Straight-Line Rent (SLR) for the portfolio is $45.4 million[8] - 77% of the top 10 tenants are Investment Grade rated[3, 4, 9] Strategic Dispositions and Leasing - The company completed the sale of 9 Times Square for $63.5 million during Q4'24[4, 7, 24] and generated net proceeds of approximately $13.5 million[7, 24] - The company completed five new leases in 2024 totaling 37,407 SF and $2.0 million of SLR[4, 23, 24] Capital Structure - The company has a 100% fixed-debt capital structure with a weighted-average debt maturity of 3.6 years at a 4.4% weighted-average interest rate[4, 27, 31, 33] - Total debt is $350 million[27, 34] and Net Leverage is 56.9%[27, 31, 32, 33] - There are no debt maturities in 2025[4, 28, 31, 33] Financial Results - Revenue from tenants was $14.9 million in Q4'24[27] - Cash NOI was $6.4 million in Q4'24, up approximately 2% year-over-year from $6.3 million in Q4'23[27, 31]